Have any questions? 706-721-6582 or cts@augusta.edu
The purpose of this study is to see if pembrolizumab in combination with olaparib helps patients live longer. Some other reasons for conducting this study are to test the safety of pembrolizumab (MK-3475) in combination with olaparib when compared to standard of care hormonal medicine, see how well pembrolizumab in combination with olaparib works when compared to standard of care hormonal medication and see if pembrolizumab in combination with olaparib helps patients have a better quality of life.